CVS Health Corporation's PBM Strong, but Retail Business Weak in 2nd Quarter
CVS Health (NYSE: CVS) didn't disappoint the last time the pharmacy giant announced its quarterly results. The company's profit was down in the first quarter, but still beat expectations. Still, CVS Health has referred to 2017 as "a rebuilding year."
The company announced its second-quarter results before the market opened on Tuesday. Did CVS Health take another positive step in its rebuilding effort? Here are the highlights from the company's second-quarter update.
Image source: Getty Images.
Source: Fool.com
CVS Health Corp. Stock
€56.70
2.920%
With 45 Buy predictions and 1 Sell predictions CVS Health Corp. is one of the favorites of our community.
With a target price of 69 € there is a positive potential of 21.69% for CVS Health Corp. compared to the current price of 56.7 €.
